Table of Content

1. Introduction


2. Research Methodology

3. Executive Summery


4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges
4.3 Opportunities


5. Porter’s Five Forces Analysis

5.1 Threat of New Entry
5.2 The Bargaining Power of Buyer
5.3 Threat of Substitution
5.4 The Bargaining Power of Supplier
5.5 Competitive Rivalry


6. Reimbursement Policy


7. Japan in Vitro Diagnostics Market


8. Market Share -Japan in Vitro Diagnostics

8.1 By Segment


9. Segments - Japan in Vitro Diagnostics Market

9.1 Urine & Faces Diagnostics
9.2 Hematology
9.3 Clinical Chemistry
9.4 Self-Blood Glucose Monitoring
9.5 Tumor Marker
9.6 Immunology
9.7 Infectious Testing
9.8 Microbiology
9.9 Pathology
9.10 Genetic Testing
9.11 Others


10. Company Analysis

10.1 Abbott Laboratories

10.1.1 Overview
10.1.2 Recent Development/Strategy
10.1.3 Sales

10.2 Danaher Corporation

10.2.1 Overview
10.2.2 Recent Development/Strategy
10.2.3 Sales

10.3 Biomerieux

10.3.1 Overview
10.3.2 Recent Development/Strategy
10.3.3 Sales

10.4 Roche Diagnostics

10.4.1 Overview
10.4.2 Recent Development/Strategy
10.4.3 Sales

10.5 Becton

10.5.1 Overview
10.5.2 Recent Development/Strategy
10.5.3 Sales



List of Figures


Figure-01: Japan– In-vitro Diagnostic Market size (Million US$), 2018 & 2024
Figure-02: Japan– In-vitro Diagnostic Top Two Rapid Growing Segment 2020 - 2026
Figure-03: Japan– In-vitro Diagnostic Largest Market Share, Immunology (Percent), 2019 -2026
Figure-04: Japan- Age-related disease type (Percentage), 2005 - 2016
Figure-05: Japan - Healthcare expenditure GDP( Percentage) 2018-2030
Figure-06: Japna - Healthcare expenditure market (Billion US$), 2005 - 2025
Figure-07: Japan- Government Healthcare Spending for 75 and older Population ( Billion US$), 2015 - 2025
Figure-08: Japan – In-vitro Diagnostics Market (Million US$), 2012 – 2019
Figure-09: Japan – Forecast for In-vitro Diagnostics Market (Million US$), 2020 – 2026
Figure-10: Japan– Urine & Faces Diagnostics Market (Million US$), 2012 – 2019
Figure-11: Japan– Forecast for Urine & Faces Diagnostics Market (Million US$), 2020 – 2026
Figure-12: Japan– Hematology Market (Million US$), 2012 – 2019
Figure-13: Japan– Forecast for Hematology Market (Million US$), 2020 – 2026
Figure-14: Japan– Clinical Chemistry Market (Million US$), 2012 – 2019
Figure-15: Japan– Forecast for Clinical Chemistry Market (Million US$), 2020 – 2026
Figure-16: Japan– SMBG Market (Million US$), 2012 – 2019
Figure-17: Japan– Forecast for SMBG Market (Million US$), 2020 – 2026
Figure-18: Japan– Tumor Marker Market (Million US$), 2012 – 2019
Figure-19: Japan– Forecast for Tumor Marker Market (Million US$), 2020 – 2026
Figure-20: Japan– Immunology Market (Million US$), 2012 – 2019
Figure-21: Japan– Forecast for Immunology Market (Million US$), 2020 – 2026
Figure-22: Japan– Infectious Disease Market (Million US$), 2012 – 2019
Figure-23: Japan– Forecast for Infectious Disease Market (Million US$), 2020 – 2026
Figure-24: Japan– Microbiology Testing Market (Million US$), 2012 – 2019
Figure-25: Japan– Forecast for Microbiology Testing Market (Million US$), 2020 – 2026
Figure-26: Japan – Pathology Market (Million US$), 2012 – 2019
Figure-27: Japan– Forecast for Pathology Market (Million US$), 2020 – 2026
Figure-28: Japan – Genetic Testing Market (Million US$), 2012 – 2019
Figure-29: Japan – Forecast for Genetic Testing Market (Million US$), 2020 – 2026
Figure-30: Japan– Others Segment Market (Million US$), 2012 – 2019
Figure-31: Japan – Forecast for Others Market (Million US$), 2020 – 2026
Figure-32: Abbott Laboratories – Global Diagnostic Sales (Million US$), 2015 - 2019
Figure-33: Abbott Laboratories – Global Forecast for Diagnostic Sales (Million US$), 2020 – 2026
Figure-34: Danaher Corporation – Global Diagnostic Sales (Million US$), 2015 - 2019
Figure-35: Danaher Corporation – Global Forecast for Diagnostic Sales (Million US$), 2020 - 2026
Figure-36: Biom?rieux– Global Diagnostic Sales (Million US$), 2015 - 2019
Figure-37: Biom?rieux – Global Forecast for Diagnostic Sales (Million US$), 2020 - 2026
Figure-38: Roche Diagnostics – Global Diagnostics Division sales (Million US$), 2015 - 2019
Figure-39: Roche Diagnostics – Global Forecast for Diagnostics Division sales (Million US$), 2020 - 2026
Figure-40: Becton – Global Diagnostics System sales (Million US$), 2015 - 2019
Figure-41: Becton – Global Forecast for Diagnostics System sales (Million US$), 2020 - 2026

 

List of Tables


Table-1: Growth Drivers % change 2005 - 2016
Table-2: Japan - Medical device & equipments reembursement policy
Table-3: Japan – In-vitro Diagnostics by Segment Market Share (Percent), 2012 – 2019
Table-4: Japan – Forecast for In-vitro Diagnostics by Segment Market Share (Percent), 2020 – 2026